Brainomix’s e-Stroke software was recently deployed across University Hospitals Sussex NHS Foundation Trust, with the software now live at Royal Sussex County Hospital in Brighton, Worthing Hospital, and at St Richard’s Hospital in Chichester. The trust is one of the largest acute trusts in the UK, covering West Sussex, Brighton and Hove, and parts of East Sussex, hosting more than 1.5 million outpatient appointments, A&E visits and surgical cases each year.
Stroke affects 110,000 people each year in the UK and it’s the 4th largest cause of death.
8 out of 10 stroke patients who leave the hospital do so with a disability. As a result, stroke costs UK society £26 billion per year. The most severe and disabling strokes are due to a large vessel occlusion (LVO).
The Sussex Integrated Stroke Delivery Network has driven the rollout of the e-Stroke software as part of its system-wide working across Sussex Health and Care Partnership and the plan is for this to be further rolled out across the ICS footprint.
The roll-out of e-Stroke in the region is part of a larger project resulting from a prestigious NHSX AI award to Brainomix in September 2020, enabling the company to deploy its software across five UK stroke networks to assess its “real world” impact on patient care.
Brainomix specialises in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions.
They launched in 2010 when they spun out of the University of Oxford.
They have developed awards-winning AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions.
NCIMI collaborating with NHS Trusts for innovation and research
January 13, 2022
Two NHS trusts at opposite ends of the UK are reaping the benefits of collaborating and being part of NCIMI.…
RAIQC joins the National Consortium of Intelligent Medical Imaging
January 5, 2022
Brainomix closes £16M financing round to expand its proven AI-enabled platform beyond stroke
December 16, 2021
A Christmas message from NCIMI COO, Mark Beggs
December 13, 2021